Screener
Nektar Therapeutics NKTR Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Nektar Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Nektar Therapeutics’s 10-Q, filed May 8, 2026. Open the filing →
- Filed
- May 7, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-212596
FAQ
- What is Nektar Therapeutics's asset turnover?
- Nektar Therapeutics (NKTR) reported asset turnover of 0.1× in Q1 2026.
- How has Nektar Therapeutics's asset turnover changed year-over-year?
- Nektar Therapeutics's asset turnover decreased by 59.2% year-over-year, from 0.3× to 0.1×.
- What is the long-term trend for Nektar Therapeutics's asset turnover?
- Over 5 years (2020 to 2025), Nektar Therapeutics's asset turnover has grown at a 16.8% compound annual growth rate (CAGR), from 0.1× to 0.2×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Nektar Therapeutics's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude